FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scanlon, K. J.
Right arrow Articles by Kashani-Sabet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scanlon, K. J.
Right arrow Articles by Kashani-Sabet, M.

The FASEB Journal, Vol 9, 1288-1296, Copyright © 1995 by The Federation of American Societies for Experimental Biology


REVIEWS

Oligonucleotide-mediated modulation of mammalian gene expression

KJ Scanlon, Y Ohta, H Ishida, H Kijima, T Ohkawa, A Kaminski, J Tsai, G Horng and M Kashani-Sabet
Department of Medical Oncology, City of Hope National Medical Center, Duarte, California 91010, USA.

The notion that oligonucleotides can modulate gene-specific expression was established more than a decade ago. Recent advances in molecular genetics have broadened the armamentarium used to manipulate gene expression in biological systems including triplex DNA, antisense RNA/DNA, and ribozymes (catalytic RNA). These oligonucleotides demonstrated important early application to the elucidation of cellular signaling pathways. More recently, studies with these agents have probed their utility as potential therapeutic agents, especially in the realm of cancer. With the implementation of gene therapy in early clinical trials, oligonucleotide-mediated suppression of gene expression has emerged as an important strategy for gene therapy. This review will discuss the current knowledge in this field, focusing on the biology of triplex DNA, antisense oligonucleotides, and ribozymes.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Zhang, D. W. Ohannesian, and L. C. Erickson
Hammerhead Ribozyme-Mediated Sensitization of Human Tumor Cells after Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 506 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Zhang, D. W. Ohannesian, E. L. Kreklau, and L. C. Erickson
Modulation of 1,3-Bis-(2-chloroethyl)-1-nitrosourea Resistance in Human Tumor Cells Using Hammerhead Ribozymes Designed to Degrade O6-Methylguanine DNA Methyltransferase mRNA
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 141 - 147.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
V Person, S Kostin, K Suzuki, S Labeit, and J Schaper
Antisense oligonucleotide experiments elucidate the essential role of titin in sarcomerogenesis in adult rat cardiomyocytes in long-term culture
J. Cell Sci., January 11, 2000; 113(21): 3851 - 3859.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
I. Dragoni, M. Mariotti, G. G. Consalez, M. R. Soria, and J. A. M. Maier
EDF-1, a Novel Gene Product Down-regulated in Human Endothelial Cell Differentiation
J. Biol. Chem., November 20, 1998; 273(47): 31119 - 31124.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
K. Lappalainen, R. Miettinen, J. Kellokoski, I. Jaaskelainen, and S. Syrjanen
Intracellular Distribution of Oligonucleotides Delivered by Cationic Liposomes: Light and Electron Microscopic Study
J. Histochem. Cytochem., February 1, 1997; 45(2): 265 - 274.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. B. Zimrin, M. S. Pepper, G. A. McMahon, F. Nguyen, R. Montesano, and T. Maciag
An Antisense Oligonucleotide to the Notch Ligand Jagged Enhances Fibroblast Growth Factor-induced Angiogenesis in Vitro
J. Biol. Chem., December 20, 1996; 271(51): 32499 - 32502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The Federation of American Societies for Experimental Biology.